SEC Filings


Form 10-Q
COLONY CAPITAL, INC. filed this Form 10-Q on 11/09/2018
Document Outline
Entire Document (20622.4 KB)
Subdocument 1 - 10-Q - FORM 10-Q
Page 1 - UNITED STATES
Page 2 - EXPLANATORY NOTE
Page 3 - COLONY CAPITAL, INC.
Page 4 - PART IFINANCIAL INFORMATION
Page 5 - COLONY CAPITAL, INC.
Page 6 - COLONY CAPITAL, INC.
Page 7 - COLONY CAPITAL, INC.
Page 8 - COLONY CAPITAL, INC.
Page 9 - COLONY CAPITAL, INC.
Page 10 - COLONY CAPITAL, INC.
Page 11 - COLONY CAPITAL, INC.
Page 12 - COLONY CAPITAL, INC.
Page 13 - Merger
Page 14 - Noncontrolling Interests
Page 15 - Impairment
Page 16 - Resident Fee Income
Page 17 - Resident Fee Income
Page 18 - Derecognition and Partial Sales of Nonfinancial Assets
Page 19 - Cash Flow Classifications
Page 20 - Future Application of Accounting Standards
Page 21 - Hedge Accounting
Page 22 - 3. Business Combinations
Page 23 - N/A
Page 24 - Real Estate and Related Intangibles
Page 25 - Investments in Unconsolidated Ventures
Page 26 - Real Estate and Related Intangibles
Page 27 - Real Estate and Related Intangibles
Page 28 - 5. Real Estate
Page 29 - Real Estate Sales
Page 30 - Depreciation and Impairment
Page 31 - 6. Loans Receivable
Page 32 - Troubled Debt Restructuring
Page 33 - Allowance for Loan Losses
Page 34 - Lending Commitments
Page 35 - Sale of Investments
Page 36 - Other Equity Investments
Page 37 - 8. Securities
Page 38 - Securities of Consolidated Funds
Page 39 - Purchased Credit-Impaired Debt Securities
Page 40 - Impairment
Page 41 - Trade Name
Page 42 - 10. Assets and Related Liabilities Held for Sale
Page 43 - Other Assets
Page 44 - 12. Debt
Page 45 - Corporate Credit Facility
Page 46 - Convertible and Exchangeable Senior Notes
Page 47 - Secured and Unsecured Debt
Page 48 - Foreign Exchange Contracts
Page 49 - Non-Designated Hedges
Page 50 - 14. Fair Value
Page 51 - Investments in Unconsolidated Ventures
Page 52 - Derivatives
Page 53 - Level 3 Recurring Fair Value Measurements
Page 54 - Transfers of Level 3 Assets and Liabilities
Page 55 - Nonrecurring Fair Values
Page 56 - Fair Value Information on Financial Instruments Reported at Cost
Page 57 - 15. Variable Interest Entities
Page 58 - Unconsolidated Securitizations
Page 59 - 16. Stockholders Equity
Page 60 - Issuance and Redemption of Preferred Stock
Page 61 - Common Stock Repurchases
Page 62 - Changes in Components of AOCI Stockholders
Page 63 - 17. Noncontrolling Interests
Page 64 - 18. Discontinued Operations
Page 65 - 19. Earnings per Share
Page 66 - 20. Fee Income
Page 67 - Asset Management Fees
Page 68 - American Healthcare Investors Joint Venture
Page 69 - Performance Stock Units ("PSUs")
Page 70 - Awards Granted by Managed Companies
Page 71 - Fee Income
Page 72 - Credit Facility
Page 73 - Advances to Employees
Page 74 - Selected Segment Results of Operations
Page 75 - N/A
Page 76 - Geography
Page 77 - 26. Subsequent Events
Page 78 - FORWARD-LOOKING STATEMENTS
Page 79 - N/A
Page 80 - Item 2. Management s Discussion and Analysis of Financial Condition and Results of Operations.
Page 81 - Our Business
Page 82 - Results of Operations
Page 83 - Consolidated Results of Operations
Page 84 - Property Operating Income and Expenses
Page 85 - Interest Income
Page 86 - Hospitality
Page 87 - Impairment Loss
Page 88 - Administrative Expense
Page 89 - Other Gain (Loss), Net
Page 90 - Comparison of the Nine Months Ended September 30, 2018 to the Nine Months Ended September 30, 2017
Page 91 - Property Operating Income and Property Operating Expenses
Page 92 - Other Equity and Debt
Page 93 - Interest Expense
Page 94 - Transaction Costs
Page 95 - Industrial
Page 96 - Gain on Sale of Real Estate
Page 97 - Other Gain (Loss), Net
Page 98 - Healthcare
Page 99 - Acquisition and Dispositions
Page 100 - Financing
Page 101 - Capitalization
Page 102 - Financing
Page 103 - Performance
Page 104 - CLNC and Other Equity and Debt
Page 105 - N/A
Page 106 - Investment Management
Page 107 - Capital Raising, Assets Under Management and Fee Earning Equity Under Management
Page 108 - Funds from Operations
Page 109 - N/A
Page 110 - Liquidity and Capital Resources
Page 111 - Preferred Stock
Page 112 - Corporate Credit Facility
Page 113 - Contractual Obligations, Commitments and Contingencies
Page 114 - Risk Management
Page 115 - Interest Rate and Foreign Currency Hedging
Page 116 - Item 3. Quantitative and Qualitative Disclosures About Market Risk.
Page 117 - Foreign Currency Risk
Page 118 - Changes in Internal Control over Financial Reporting
Page 119 - PART II OTHER INFORMATION
Page 120 - Amendment to NRE Management Agreement
Page 121 - Item 6. Exhibits.
Page 122 - SIGNATURES
Subdocument 2 - EX-10.1 - AMENDED AND RESTATED ASSET MANAGEMENT AGREEMENT
Page 1 - Exhibit 10.1
Page 2 - Incentive Fee.
Page 3 - N/A
Subdocument 3 - EX-10.2 - AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT
Page 1 - Exhibit 10.2
Page 2 - Signature page follows
Page 3 - [Signature Page to Amendment No. 4 to the Third Amended and Restated Limited Liability Company Agree
Subdocument 4 - EX-31.1 - SECTION 302 CERTIFICATION OF CHIEF EXECUTIVE OFFICER
Page 1 - N/A
Subdocument 5 - EX-31.2 - SECTION 302 CERTIFICATION OF CHIEF FINANCIAL OFFICER
Page 1 - N/A
Subdocument 6 - EX-32.1 - SECTION 906 CERTIFICATION OF CHIEF EXECUTIVE OFFICER
Page 1 - N/A
Subdocument 7 - EX-32.2 - SECTION 906 CERTIFICATION OF CHIEF FINANCIAL OFFICER
Page 1 - N/A
XBRL Item - EX-101.INS - XBRL INSTANCE DOCUMENT (What's this?)
XBRL Item - EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT (What's this?)
XBRL Item - EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT (What's this?)
XBRL Item - EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT (What's this?)
XBRL Item - EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT (What's this?)
XBRL Item - EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT (What's this?)
XBRL Viewer

Shareholder Contact Information

Investor Relations

Lasse Glassen
ADDO Communications
310.829.5400
lglassen@addoir.com

Press & Media

Caroline Luz
Owen Blicksilver P.R., Inc.
203.656.2829
caroline@blicksilverpr.com

Stock & Transfer Agent

American Stock & Transfer
Trust Company
800.937.5449
www.amstock.com/main/